Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRM dose-finding study of intraoperative remifentanil for postoperative hyperalgesia
ChiCTR-TNC-11001520Phase 4Completed
- Sponsor
- First Hospital of China Medical University
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil in pain, sponsored by First Hospital of China Medical University. Primary endpoints: Maximum pain detection threshold intensity and Minimum pain detection threshold intensity. Started Jun 2009; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR-TNC-11001520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001520.